Ibrutinib plus standard chemotherapy effective in younger patients with diffuse large B-cell lymphoma

By | November 5, 2021
Younger patients with specific genetic subtypes of non-GCB DLBCL, called MCD and N1, had an exceptional response to the treatment combination.